Compound 3
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1ccccc1)c1c2[nH]n(-c2ccc(Cl)cc2)c1=O
- InChi:
InChI=1S/C20H14ClN5O/c1-25-19-15(11-22-25)18-16(17(23-19)12-5-3-2-4-6-12)20(27)26(24-18)14-9-7-13(21)8-10-14/h2-11,24H,1H3
- InChiKey:
JVMVERZOOQABAE-UHFFFAOYSA-N
External search
Bibliography (2)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 5.74 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 375.09 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 4.72 | |||
TPSA | 63.05 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
2 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5307 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4857 | ATX-914 | DB12673 | |
0.4605 | Riociguat | DB08931 | |
0.4533 | 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE | DB07606 | |
0.4533 | MK-6186 | DB12999 | |
0.4506 | Antipyrine | DB01435 | |
0.4500 | Tepotinib | DB15133 | |
0.4497 | Methaqualone | DB04833 | |
0.4471 | 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08531 | |
0.4462 | ABT-288 | DB15192 | |
0.4451 | 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL | DB07712 | |
0.4449 | Vericiguat | DB15456 | |
0.4433 | 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DB08054 | |
0.4418 | 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB07210 | |
0.4404 | Ravoxertinib | DB15281 |